Which forms of cancer is the Tpl2 gene associated with?
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/umls/label/A12009979","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["UMLS Label"]},"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://www.w3.org/2008/05/skos-xl#Label"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#notation","subj":null,"obj":"608304"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#note","subj":null,"obj":"OMIM"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["CT95","CTAG3","CAGE1 gene","CAGE1","CANCER-ASSOCIATED GENE 1","bA69L16.7","cancer antigen 1","cancer/testis antigen 95","CANCER/TESTIS ANTIGEN 3"]},"pred":"http://www.w3.org/2008/05/skos-xl#altLabel","subj":"http://linkedlifedata.com/resource/umls/id/C1538431","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2008/05/skos-xl#literalForm","subj":null,"obj":"CANCER-ASSOCIATED GENE 1"}]},"score":0.50482005}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/umls/label/A16694014","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["UMLS Label"]},"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://www.w3.org/2008/05/skos-xl#Label"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#notation","subj":null,"obj":"20083"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#note","subj":null,"obj":"HUGO"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["DDX53 gene","cancer/testis antigen 26","CT26","DEAD (Asp-Glu-Ala-Asp) box polypeptide 53","cancer associated gene","DDX53","CAGE"]},"pred":"http://www.w3.org/2008/05/skos-xl#altLabel","subj":"http://linkedlifedata.com/resource/umls/id/C1426669","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2008/05/skos-xl#literalForm","subj":null,"obj":"cancer associated gene"}]},"score":0.50482005}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/#_51375A3741330018","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Cytoplasmic tRNA 2-thiolation protein 1","Cytoplasmic tRNA adenylyltransferase 1","ATP-binding domain-containing protein 3","Cancer-associated gene protein"]},"pred":"http://purl.uniprot.org/core/alternativeName","subj":"http://purl.uniprot.org/uniprot/Q7Z7A3","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/fullName","subj":null,"obj":"Cancer-associated gene protein"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Structured_Name"}]},"score":0.4999489}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/#_513836544D330017","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["DEAD box protein 53","Probable ATP-dependent RNA helicase DDX53","Cancer/testis antigen 26","CT26","Cancer-associated gene protein","DEAD box protein CAGE"]},"pred":"http://purl.uniprot.org/core/alternativeName","subj":"http://purl.uniprot.org/uniprot/Q86TM3","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/fullName","subj":null,"obj":"Cancer-associated gene protein"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Structured_Name"}]},"score":0.4992063}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/umls/label/A16696725","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["UMLS Label"]},"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://www.w3.org/2008/05/skos-xl#Label"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#notation","subj":null,"obj":"16353"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#note","subj":null,"obj":"HUGO"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["MGC8386","MAGED2 gene","BCG1","MAGED","MAGED2","breast cancer associated gene 1","melanoma-associated antigen D2","hepatocellular carcinoma-associated protein HCA10","JCL-1","HCA10","melanoma antigen family D, 2","11B6","MAGE-D2","hepatocellular carcinoma associated protein","MELANOMA ANTIGEN, FAMILY D, 2"]},"pred":"http://www.w3.org/2008/05/skos-xl#altLabel","subj":"http://linkedlifedata.com/resource/umls/id/C1424211","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2008/05/skos-xl#literalForm","subj":null,"obj":"breast cancer associated gene 1"}]},"score":0.44432276}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/umls/label/A12010223","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["OVARIAN CANCER-ASSOCIATED GENE 2","OVCA2 gene","ovarian tumor suppressor candidate 2","candidate tumor suppressor in ovarian cancer 2","OVCA2"]},"pred":"http://linkedlifedata.com/resource/umls/prefMetaMap","subj":"http://linkedlifedata.com/resource/umls/id/C1842848","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["UMLS Label"]},"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://www.w3.org/2008/05/skos-xl#Label"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#notation","subj":null,"obj":"607896"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#note","subj":null,"obj":"OMIM"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["OVARIAN CANCER-ASSOCIATED GENE 2","OVCA2 gene","ovarian tumor suppressor candidate 2","candidate tumor suppressor in ovarian cancer 2","OVCA2"]},"pred":"http://www.w3.org/2008/05/skos-xl#altLabel","subj":"http://linkedlifedata.com/resource/umls/id/C1842848","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2008/05/skos-xl#literalForm","subj":null,"obj":"OVARIAN CANCER-ASSOCIATED GENE 2"}]},"score":0.44412082}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/umls/label/A12023572","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["UMLS Label"]},"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://www.w3.org/2008/05/skos-xl#Label"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#notation","subj":null,"obj":"609191"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#note","subj":null,"obj":"OMIM"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["C11ORF17","PROTEIN KINASE A-INTERACTING PROTEIN 1","chromosome 11 open reading frame 17","AKIP1","C11orf17","BCA3","BREAST CANCER-ASSOCIATED GENE 3","C11orf17 gene","PKA-INTERACTING PROTEIN 1","CHROMOSOME 11 OPEN READING FRAME 17"]},"pred":"http://www.w3.org/2008/05/skos-xl#altLabel","subj":"http://linkedlifedata.com/resource/umls/id/C1412869","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2008/05/skos-xl#literalForm","subj":null,"obj":"BREAST CANCER-ASSOCIATED GENE 3"}]},"score":0.44412082}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/umls/label/A8427101","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["UMLS Label"]},"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://www.w3.org/2008/05/skos-xl#Label"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#notation","subj":null,"obj":"C454199"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#note","subj":null,"obj":"MeSH"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["DEAD (Asp-Glu-Ala-Asp) box polypeptide 53, human","DDX53 protein, human","CAGE protein, human","cancer associated gene protein, human","cancer-associated gene protein, human"]},"pred":"http://www.w3.org/2008/05/skos-xl#altLabel","subj":"http://linkedlifedata.com/resource/umls/id/C1122319","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2008/05/skos-xl#literalForm","subj":null,"obj":"cancer-associated gene protein, human"}]},"score":0.44412082}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/umls/label/A12086062","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["UMLS Label"]},"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://www.w3.org/2008/05/skos-xl#Label"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#notation","subj":null,"obj":"C454199"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#note","subj":null,"obj":"MeSH"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["DEAD (Asp-Glu-Ala-Asp) box polypeptide 53, human","DDX53 protein, human","CAGE protein, human","cancer associated gene protein, human","cancer-associated gene protein, human"]},"pred":"http://www.w3.org/2008/05/skos-xl#altLabel","subj":"http://linkedlifedata.com/resource/umls/id/C1122319","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2008/05/skos-xl#literalForm","subj":null,"obj":"cancer associated gene protein, human"}]},"score":0.44388333}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/umls/label/A11970127","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["UMLS Label"]},"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://www.w3.org/2008/05/skos-xl#Label"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#notation","subj":null,"obj":"603527"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#note","subj":null,"obj":"OMIM"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["OVARIAN CANCER-ASSOCIATED GENE 1","DPH2L1","DPH1 homolog (S. cerevisiae)","OVCA1","DPH1","DPH2-LIKE 1","DPH1 gene","ovarian tumor suppressor candidate 1","DPH1, S. CEREVISIAE, HOMOLOG OF"]},"pred":"http://www.w3.org/2008/05/skos-xl#altLabel","subj":"http://linkedlifedata.com/resource/umls/id/C1824959","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2008/05/skos-xl#literalForm","subj":null,"obj":"OVARIAN CANCER-ASSOCIATED GENE 1"}]},"score":0.44356814}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/#_423951324839008","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/fullName","subj":null,"obj":"Cancer-associated gene protein, putative"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/submittedName","subj":"http://purl.uniprot.org/uniprot/B9Q2H9","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#subject","subj":"http://linkedlifedata.com/resource/#_423951324839009","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Structured_Name"}]},"score":0.43921995}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/#_453057304B35005","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/fullName","subj":null,"obj":"Cancer-associated gene protein, putative"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/submittedName","subj":"http://purl.uniprot.org/uniprot/E0W0K5","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#subject","subj":"http://linkedlifedata.com/resource/#_453057304B35006","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Structured_Name"}]},"score":0.43868056}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/#_453057304B36005","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/fullName","subj":null,"obj":"Cancer-associated gene protein, putative"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/submittedName","subj":"http://purl.uniprot.org/uniprot/E0W0K6","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#subject","subj":"http://linkedlifedata.com/resource/#_453057304B36006","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Structured_Name"}]},"score":0.43847176}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/#_51385443323000B","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/fullName","subj":null,"obj":"Cancer-associated gene 1 protein"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["CT3","Cancer-associated gene 1 protein","CAGE-1","Cancer/testis antigen 3"]},"pred":"http://purl.uniprot.org/core/recommendedName","subj":"http://purl.uniprot.org/uniprot/Q8TC20","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/shortName","subj":null,"obj":"CAGE-1"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Structured_Name"}]},"score":0.43847176}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/umls/label/A8395078","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Cancer Gene","Genes, Cancer","Cancer Genes","Gene, Cancer","Cancer-Promoting Gene","Cancer Promoting Genes"]},"pred":"http://linkedlifedata.com/resource/umls/altMetaMap","subj":"http://linkedlifedata.com/resource/umls/id/C0919437","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["UMLS Label"]},"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://www.w3.org/2008/05/skos-xl#Label"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#notation","subj":null,"obj":"D052138"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#note","subj":null,"obj":"MeSH"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Cancer Gene","Genes, Cancer","Cancer Genes","Gene, Cancer","Cancer-Promoting Gene","Cancer Promoting Genes"]},"pred":"http://www.w3.org/2008/05/skos-xl#altLabel","subj":"http://linkedlifedata.com/resource/umls/id/C0919437","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2008/05/skos-xl#literalForm","subj":null,"obj":"Cancer Genes"}]},"score":0.40230468}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/umls/label/A8395216","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["UMLS Label"]},"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://www.w3.org/2008/05/skos-xl#Label"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#notation","subj":null,"obj":"D052138"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#note","subj":null,"obj":"MeSH"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Cancer Gene","Genes, Cancer","Cancer Genes","Gene, Cancer","Cancer-Promoting Gene","Cancer Promoting Genes"]},"pred":"http://www.w3.org/2008/05/skos-xl#altLabel","subj":"http://linkedlifedata.com/resource/umls/id/C0919437","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2008/05/skos-xl#literalForm","subj":null,"obj":"Gene, Cancer"}]},"score":0.402126}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/umls/label/A8395220","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["UMLS Label"]},"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://www.w3.org/2008/05/skos-xl#Label"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#notation","subj":null,"obj":"D052138"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#note","subj":null,"obj":"MeSH"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Cancer Gene","Genes, Cancer","Cancer Genes","Gene, Cancer","Cancer-Promoting Gene","Cancer Promoting Genes"]},"pred":"http://www.w3.org/2008/05/skos-xl#altLabel","subj":"http://linkedlifedata.com/resource/umls/id/C0919437","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2008/05/skos-xl#literalForm","subj":null,"obj":"Genes, Cancer"}]},"score":0.4019021}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/umls/label/A8395077","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Cancer Gene","Genes, Cancer","Cancer Genes","Gene, Cancer","Cancer-Promoting Gene","Cancer Promoting Genes"]},"pred":"http://linkedlifedata.com/resource/umls/altMetaMap","subj":"http://linkedlifedata.com/resource/umls/id/C0919437","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["UMLS Label"]},"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://www.w3.org/2008/05/skos-xl#Label"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#notation","subj":null,"obj":"D052138"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#note","subj":null,"obj":"MeSH"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Cancer Gene","Genes, Cancer","Cancer Genes","Gene, Cancer","Cancer-Promoting Gene","Cancer Promoting Genes"]},"pred":"http://www.w3.org/2008/05/skos-xl#altLabel","subj":"http://linkedlifedata.com/resource/umls/id/C0919437","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2008/05/skos-xl#literalForm","subj":null,"obj":"Cancer Gene"}]},"score":0.40180802}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/umls/label/A7569305","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Cancer Gene","Genes, Cancer","Cancer Genes","Gene, Cancer","Cancer-Promoting Gene","Cancer Promoting Genes"]},"pred":"http://linkedlifedata.com/resource/umls/altMetaMap","subj":"http://linkedlifedata.com/resource/umls/id/C0919437","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["UMLS Label"]},"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://www.w3.org/2008/05/skos-xl#Label"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#notation","subj":null,"obj":"C19540"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#note","subj":null,"obj":"NCI Thesaurus"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Cancer Gene","Genes, Cancer","Cancer Genes","Gene, Cancer","Cancer-Promoting Gene","Cancer Promoting Genes"]},"pred":"http://www.w3.org/2008/05/skos-xl#altLabel","subj":"http://linkedlifedata.com/resource/umls/id/C0919437","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2008/05/skos-xl#literalForm","subj":null,"obj":"Cancer Gene"}]},"score":0.4016151}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/umls/label/A16606794","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["UMLS Label"]},"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://www.w3.org/2008/05/skos-xl#Label"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#notation","subj":null,"obj":"612646"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#note","subj":null,"obj":"OMIM"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["METASTASIS-ASSOCIATED GENE IN COLON CANCER 1","metastasis associated in colon cancer 1","7A5","MACC1 gene","SH3BP4L","MACC1"]},"pred":"http://www.w3.org/2008/05/skos-xl#altLabel","subj":"http://linkedlifedata.com/resource/umls/id/C2675234","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2008/05/skos-xl#literalForm","subj":null,"obj":"METASTASIS-ASSOCIATED GENE IN COLON CANCER 1"}]},"score":0.38282773}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/umls/label/A8597463","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["UMLS Label"]},"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://www.w3.org/2008/05/skos-xl#Label"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#notation","subj":null,"obj":"C471621"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#note","subj":null,"obj":"MeSH"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Breast cancer-associated gene 3 protein, human","chromosome 11 open reading frame 17 protein, human","BCA3 protein, human","C11orf17 protein, human","PKA-interacting protein, human","AKIP1 protein, human"]},"pred":"http://www.w3.org/2008/05/skos-xl#altLabel","subj":"http://linkedlifedata.com/resource/umls/id/C1174539","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2008/05/skos-xl#literalForm","subj":null,"obj":"Breast cancer-associated gene 3 protein, human"}]},"score":0.38282773}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/umls/label/A8427100","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["UMLS Label"]},"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://www.w3.org/2008/05/skos-xl#Label"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#notation","subj":null,"obj":"C473315"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#note","subj":null,"obj":"MeSH"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["CAGE-1 protein, human","cancer-associated gene 1 protein, human","cancer-testis antigen CAGE-1, human","CAGE1 protein, human"]},"pred":"http://www.w3.org/2008/05/skos-xl#altLabel","subj":"http://linkedlifedata.com/resource/umls/id/C1175872","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2008/05/skos-xl#literalForm","subj":null,"obj":"cancer-associated gene 1 protein, human"}]},"score":0.3825871}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/umls/label/A9372699","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["UMLS Label"]},"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://www.w3.org/2008/05/skos-xl#Label"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#notation","subj":null,"obj":"C506934"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#note","subj":null,"obj":"MeSH"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["ZNF364 protein, human","zinc finger protein 364 protein, human","BCA2 protein, human","breast cancer-associated gene 2 protein, human","RNF115 protein, human","Rabring7 protein, human","ring finger protein 115, human"]},"pred":"http://www.w3.org/2008/05/skos-xl#altLabel","subj":"http://linkedlifedata.com/resource/umls/id/C1666243","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2008/05/skos-xl#literalForm","subj":null,"obj":"breast cancer-associated gene 2 protein, human"}]},"score":0.38231617}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/umls/label/A13291406","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["UMLS Label"]},"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://www.w3.org/2008/05/skos-xl#Label"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#notation","subj":null,"obj":"610958"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#note","subj":null,"obj":"OMIM"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["1-@ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 8","HMFN0839","MAG1","GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE 3","GPAT3","LPAAT-theta","LPAAT-THETA","AGPAT8","LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE, THETA","lysophosphatidic acid acyltransferase, theta","LUNG CANCER METASTASIS-ASSOCIATED GENE 1","MGC11324","GPAT, ENDOPLASMIC RETICULUM-ASSOCIATED","AGPAT9","1-acylglycerol-3-phosphate O-acyltransferase 9","AGPAT9 gene"]},"pred":"http://www.w3.org/2008/05/skos-xl#altLabel","subj":"http://linkedlifedata.com/resource/umls/id/C1970419","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2008/05/skos-xl#literalForm","subj":null,"obj":"LUNG CANCER METASTASIS-ASSOCIATED GENE 1"}]},"score":0.3819234}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/umls/label/A7631938","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["UMLS Label"]},"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://www.w3.org/2008/05/skos-xl#Label"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#notation","subj":null,"obj":"C20919"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#note","subj":null,"obj":"NCI Thesaurus"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Breast Cancer, 11;22 Translocation Associated Gene","BRCATA Gene","BRCATA"]},"pred":"http://www.w3.org/2008/05/skos-xl#altLabel","subj":"http://linkedlifedata.com/resource/umls/id/C1332440","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2008/05/skos-xl#literalForm","subj":null,"obj":"Breast Cancer, 11;22 Translocation Associated Gene"}]},"score":0.3819234}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/#_51354E4351350013","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["DPH2-like 1","DPH1 homolog","MmDph1","Diphthamide biosynthesis protein 2 homolog-like 1","Diphthamide biosynthesis protein 1","Ovarian cancer-associated gene 1 protein homolog"]},"pred":"http://purl.uniprot.org/core/alternativeName","subj":"http://purl.uniprot.org/uniprot/Q5NCQ5","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/fullName","subj":null,"obj":"Ovarian cancer-associated gene 1 protein homolog"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Structured_Name"}]},"score":0.37786284}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/#_51394437453300B","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/fullName","subj":null,"obj":"Ovarian cancer-associated gene 2 protein homolog"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Ovarian cancer-associated gene 2 protein homolog"]},"pred":"http://purl.uniprot.org/core/recommendedName","subj":"http://purl.uniprot.org/uniprot/Q9D7E3","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Structured_Name"}]},"score":0.37786284}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/#_51354952373000C","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/fullName","subj":null,"obj":"Cancer-associated gene 1 protein homolog"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Cancer/testis antigen 3 homolog","CAGE-1","CT3 homolog","Cancer-associated gene 1 protein homolog"]},"pred":"http://purl.uniprot.org/core/recommendedName","subj":"http://purl.uniprot.org/uniprot/Q5IR70","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/shortName","subj":null,"obj":"CAGE-1"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Structured_Name"}]},"score":0.37772837}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/#_5138575A383200E","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/fullName","subj":null,"obj":"Ovarian cancer-associated gene 2 protein"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Ovarian cancer-associated gene 2 protein"]},"pred":"http://purl.uniprot.org/core/recommendedName","subj":"http://purl.uniprot.org/uniprot/Q8WZ82","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Structured_Name"}]},"score":0.37772837}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/#_433143304A39009","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/fullName","subj":null,"obj":"Ovarian cancer-associated gene 2 protein homolog"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/submittedName","subj":"http://purl.uniprot.org/uniprot/C1C0J9","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#subject","subj":"http://linkedlifedata.com/resource/#_433143304A3900A","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Structured_Name"}]},"score":0.37769228}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/#_42355837543400E","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/fullName","subj":null,"obj":"Ovarian cancer-associated gene 2 protein homolog"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/submittedName","subj":"http://purl.uniprot.org/uniprot/B5X7T4","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#subject","subj":"http://linkedlifedata.com/resource/#_42355837543400F","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Structured_Name"}]},"score":0.3774889}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/#_5139354A523000C","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/fullName","subj":null,"obj":"Cancer-associated gene 1 protein homolog"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["CAGE-1","Cancer-associated gene 1 protein homolog"]},"pred":"http://purl.uniprot.org/core/recommendedName","subj":"http://purl.uniprot.org/uniprot/Q95JR0","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/shortName","subj":null,"obj":"CAGE-1"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Structured_Name"}]},"score":0.3774889}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/#_5139554E46310037","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["MAGE-D2 antigen","Breast cancer-associated gene 1 protein","11B6","BCG-1","Melanoma-associated antigen D2","Hepatocellular carcinoma-associated protein JCL-1"]},"pred":"http://purl.uniprot.org/core/alternativeName","subj":"http://purl.uniprot.org/uniprot/Q9UNF1","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/fullName","subj":null,"obj":"Breast cancer-associated gene 1 protein"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/shortName","subj":null,"obj":"BCG-1"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Structured_Name"}]},"score":0.3774889}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/#_413449493733006","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/fullName","subj":null,"obj":"Ovarian cancer-associated gene 2 protein homolog"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Ovarian cancer-associated gene 2 protein homolog"]},"pred":"http://purl.uniprot.org/core/recommendedName","subj":"http://purl.uniprot.org/uniprot/A4II73","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Structured_Name"}]},"score":0.37739903}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/#_5133535A3037006","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/fullName","subj":null,"obj":"Ovarian cancer-associated gene 2 protein homolog"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Ovarian cancer-associated gene 2 protein homolog"]},"pred":"http://purl.uniprot.org/core/recommendedName","subj":"http://purl.uniprot.org/uniprot/Q3SZ07","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Structured_Name"}]},"score":0.3773893}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/#_513636484236003","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/fullName","subj":null,"obj":"Cancer-associated gene 1 protein homolog"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Cancer/testis antigen 3 homolog","CAGE-1","CT3 homolog","Cancer-associated gene 1 protein homolog"]},"pred":"http://purl.uniprot.org/core/recommendedName","subj":"http://purl.uniprot.org/uniprot/Q66HB6","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/shortName","subj":null,"obj":"CAGE-1"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Structured_Name"}]},"score":0.3773893}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/#_5139425A47380018","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["DPH2-like 1","DPH-like 1","HsDph1","DPH1 homolog","Diphthamide biosynthesis protein 2 homolog-like 1","Diphthamide biosynthesis protein 1","Ovarian cancer-associated gene 1 protein","Diphthamide biosynthesis protein 2-like"]},"pred":"http://purl.uniprot.org/core/alternativeName","subj":"http://purl.uniprot.org/uniprot/Q9BZG8","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/fullName","subj":null,"obj":"Ovarian cancer-associated gene 1 protein"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Structured_Name"}]},"score":0.3773893}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/#_51394E51333100B","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Breast cancer-associated gene 3 protein","AKIP1","Proline-rich protein BCA3","PKA-interacting protein"]},"pred":"http://purl.uniprot.org/core/alternativeName","subj":"http://purl.uniprot.org/uniprot/Q9NQ31","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/fullName","subj":null,"obj":"Breast cancer-associated gene 3 protein"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Structured_Name"}]},"score":0.3773893}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/#_4331425A5A32009","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/fullName","subj":null,"obj":"Ovarian cancer-associated gene 2 protein homolog"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/submittedName","subj":"http://purl.uniprot.org/uniprot/C1BZZ2","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#subject","subj":"http://linkedlifedata.com/resource/#_4331425A5A3200A","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Structured_Name"}]},"score":0.3772198}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/#_513530335934005","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/fullName","subj":null,"obj":"Ovarian cancer-associated gene 2 protein homolog"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Ovarian cancer-associated gene 2 protein homolog"]},"pred":"http://purl.uniprot.org/core/recommendedName","subj":"http://purl.uniprot.org/uniprot/Q503Y4","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Structured_Name"}]},"score":0.37683022}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/#_51394A4A5235008","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Breast cancer-associated gene 3 protein","AKIP1","Proline-rich protein BCA3","PKA-interacting protein"]},"pred":"http://purl.uniprot.org/core/alternativeName","subj":"http://purl.uniprot.org/uniprot/Q9JJR5","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/fullName","subj":null,"obj":"Breast cancer-associated gene 3 protein"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Structured_Name"}]},"score":0.37683022}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/#_41395A50303700F","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/encodedBy","subj":"http://purl.uniprot.org/uniprot/A9ZP07","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#subject","subj":"http://linkedlifedata.com/resource/#_41395A5030370010","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Gene"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#prefLabel","subj":null,"obj":"ofs"}]},"score":0.3439938}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/#_5139564348310013","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/encodedBy","subj":"http://purl.uniprot.org/uniprot/Q9VCH1","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/orfName","subj":null,"obj":"CG10192"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/orfName","subj":null,"obj":"Dmel_CG10192"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#subject","subj":"http://linkedlifedata.com/resource/#_5139564348310018","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#subject","subj":"http://linkedlifedata.com/resource/#_5139564348310019","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#subject","subj":"http://linkedlifedata.com/resource/#_5139564348310014","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#subject","subj":"http://linkedlifedata.com/resource/#_5139564348310017","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Gene"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#altLabel","subj":null,"obj":"ofs"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#prefLabel","subj":null,"obj":"eIF4G2"}]},"score":0.34188038}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/#_41325445563500F","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/encodedBy","subj":"http://purl.uniprot.org/uniprot/A2TEV5","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#subject","subj":"http://linkedlifedata.com/resource/#_4132544556350010","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Gene"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#prefLabel","subj":null,"obj":"ofs"}]},"score":0.33881083}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/#_51385434463900E","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/encodedBy","subj":"http://purl.uniprot.org/uniprot/Q8T4F9","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/orfName","subj":null,"obj":"CG10192"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#subject","subj":"http://linkedlifedata.com/resource/#_51385434463900F","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#subject","subj":"http://linkedlifedata.com/resource/#_5138543446390012","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#subject","subj":"http://linkedlifedata.com/resource/#_5138543446390013","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Gene"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#altLabel","subj":null,"obj":"ofs"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#prefLabel","subj":null,"obj":"eIF4G2"}]},"score":0.33769587}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/#_43304D3634340013","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/encodedBy","subj":"http://purl.uniprot.org/uniprot/C0M644","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#subject","subj":"http://linkedlifedata.com/resource/#_43304D3634340014","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Gene"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#prefLabel","subj":null,"obj":"ofs"}]},"score":0.33495474}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/umls/label/A11933217","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Osteolysis, familial expansile","FAMILIAL EXPANSILE OSTEOLYSIS","FEO","OFE","HEPOD","Polyostotic osteolytic dysplasia, hereditary expansile","EXPANSILE OSTEOLYSIS, FAMILIAL","OSTEOLYSIS, FAMILIAL EXPANSILE","Familial expansile osteolysis","POLYOSTOTIC OSTEOLYTIC DYSPLASIA, HEREDITARY EXPANSILE","EOF","MCCABE DISEASE","Expansile osteolysis, familial","McCabe disease"]},"pred":"http://linkedlifedata.com/resource/umls/altMetaMap","subj":"http://linkedlifedata.com/resource/umls/id/C0432292","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["UMLS Label"]},"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://www.w3.org/2008/05/skos-xl#Label"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#notation","subj":null,"obj":"174810"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#note","subj":null,"obj":"OMIM"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Osteolysis, familial expansile","FAMILIAL EXPANSILE OSTEOLYSIS","FEO","OFE","HEPOD","Polyostotic osteolytic dysplasia, hereditary expansile","EXPANSILE OSTEOLYSIS, FAMILIAL","OSTEOLYSIS, FAMILIAL EXPANSILE","Familial expansile osteolysis","POLYOSTOTIC OSTEOLYTIC DYSPLASIA, HEREDITARY EXPANSILE","EOF","MCCABE DISEASE","Expansile osteolysis, familial","McCabe disease"]},"pred":"http://www.w3.org/2008/05/skos-xl#altLabel","subj":"http://linkedlifedata.com/resource/umls/id/C0432292","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2008/05/skos-xl#literalForm","subj":null,"obj":"OFE"}]},"score":0.3337163}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/#_41395A50313000B","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/encodedBy","subj":"http://purl.uniprot.org/uniprot/A9ZP10","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#subject","subj":"http://linkedlifedata.com/resource/#_41395A50313000C","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Gene"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#prefLabel","subj":null,"obj":"ofs"}]},"score":0.3328223}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/#_51335A4A46380017","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/encodedBy","subj":"http://purl.uniprot.org/uniprot/Q3ZJF8","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#subject","subj":"http://linkedlifedata.com/resource/#_51335A4A46380018","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Gene"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#prefLabel","subj":null,"obj":"ofs"}]},"score":0.33248794}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://linkedlifedata.com/resource/#_41395A50303800B","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/encodedBy","subj":"http://purl.uniprot.org/uniprot/A9ZP08","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#subject","subj":"http://linkedlifedata.com/resource/#_41395A50303800C","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Gene"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#prefLabel","subj":null,"obj":"ofs"}]},"score":0.32831174}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/citations/10398436","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/(SICI)1098-2264(199908)25:4<399::AID-GCC14>3.3.CO;2-O"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Catenin beta-1","Beta-catenin"]},"pred":"http://purl.uniprot.org/core/citation","subj":"http://purl.uniprot.org/uniprot/P35222","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["EC33"]},"pred":"http://purl.uniprot.org/core/source","subj":"http://linkedlifedata.com/resource/#_5033353232320010D","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Beta-catenin accumulation and mutation of the CTNNB1 gene in hepatoblastoma."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"25"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#object","subj":"http://linkedlifedata.com/resource/#_5033353232320041","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/10398436"}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/citations/11433525","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.1153"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/citation","subj":"http://purl.uniprot.org/uniprot/Q9JIJ8","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/citation","subj":"http://purl.uniprot.org/uniprot/Q9JIJ7","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Amplification of Mycn, Ddx1, Rrm2, and Odc1 in rat uterine endometrial carcinomas."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"31"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#object","subj":"http://linkedlifedata.com/resource/#_51394A494A38001","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#object","subj":"http://linkedlifedata.com/resource/#_51394A494A37001","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/medline/21325992"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/11433525"}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/citations/12112524","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.10033"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["CD246","ALK tyrosine kinase receptor","Anaplastic lymphoma kinase"]},"pred":"http://purl.uniprot.org/core/citation","subj":"http://purl.uniprot.org/uniprot/Q9UM73","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Protein ALO17","ALK lymphoma oligomerization partner on chromosome 17"]},"pred":"http://purl.uniprot.org/core/citation","subj":"http://purl.uniprot.org/uniprot/Q9HCF4","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Cysteinyl-tRNA synthetase, cytoplasmic","CysRS","Cysteine--tRNA ligase"]},"pred":"http://purl.uniprot.org/core/citation","subj":"http://purl.uniprot.org/uniprot/P49589","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"34"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#object","subj":"http://linkedlifedata.com/resource/#_513948434634006","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#object","subj":"http://linkedlifedata.com/resource/#_503439353839008","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#object","subj":"http://linkedlifedata.com/resource/#_5139554D373300A","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/medline/22105993"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/12112524"}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/citations/12353266","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.10115"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Glycoprotein 340","Salivary agglutinin","Gp-340","Surfactant pulmonary-associated D-binding protein","Hensin","Deleted in malignant brain tumors 1 protein","SAG"]},"pred":"http://purl.uniprot.org/core/citation","subj":"http://purl.uniprot.org/uniprot/Q9UGM3","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["EC18"]},"pred":"http://purl.uniprot.org/core/source","subj":"http://linkedlifedata.com/resource/#_513955474D3300183","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"The SRCR/SID region of DMBT1 defines a complex multi-allele system representing the major basis for its variability in cancer."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"35"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#object","subj":"http://linkedlifedata.com/resource/#_513955474D330020","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/12353266"}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/citations/12557231","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.10176"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["PR domain zinc finger protein 16","Transcription factor MEL1","PR domain-containing protein 16","MDS1/EVI1-like gene 1"]},"pred":"http://purl.uniprot.org/core/citation","subj":"http://purl.uniprot.org/uniprot/Q9HAZ2","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["EC5"]},"pred":"http://purl.uniprot.org/core/source","subj":"http://linkedlifedata.com/resource/#_513948415A32002F","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Breakpoints at 1p36.3 in three MDS/AML(M4) patients with t(1;3)(p36;q21) occur in the first intron and in the 5' region of MEL1."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"36"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#object","subj":"http://linkedlifedata.com/resource/#_513948415A3200B","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/12557231"}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/citations/15034873","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.20023"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["FGFR-1","CD331","Basic fibroblast growth factor receptor 1","bFGF-R-1","Proto-oncogene c-Fgr","FLT-2","Fms-like tyrosine kinase 2"]},"pred":"http://purl.uniprot.org/core/citation","subj":"http://purl.uniprot.org/uniprot/P11362","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["FGFR1 oncogene partner 2"]},"pred":"http://purl.uniprot.org/core/citation","subj":"http://purl.uniprot.org/uniprot/Q9NVK5","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndrome."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"40"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#object","subj":"http://linkedlifedata.com/resource/#_51394E564B3500A","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#object","subj":"http://linkedlifedata.com/resource/#_503131333632002D","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/15034873"}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/citations/15139001","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.20037"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["cAMP-responsive element-binding protein 3-like protein 2","Cyclic AMP-responsive element-binding protein 3-like protein 2","BBF2 human homolog on chromosome 7"]},"pred":"http://purl.uniprot.org/core/citation","subj":"http://purl.uniprot.org/uniprot/Q70SY1","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"40"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#object","subj":"http://linkedlifedata.com/resource/#_51373053593100A","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/15139001"}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/citations/15139004","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.20040"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["MutL protein homolog 1","DNA mismatch repair protein Mlh1"]},"pred":"http://purl.uniprot.org/core/citation","subj":"http://purl.uniprot.org/uniprot/P40692","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["EC56"]},"pred":"http://purl.uniprot.org/core/source","subj":"http://linkedlifedata.com/resource/#_50343036393200BD","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"HNPCC mutation MLH1 P648S makes the functional protein unstable, and homozygosity predisposes to mild neurofibromatosis type 1."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"40"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#object","subj":"http://linkedlifedata.com/resource/#_5034303639320059","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/15139004"}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/citations/16175573","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.20265"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["SCFR","Tyrosine-protein kinase Kit","Mast/stem cell growth factor receptor","Proto-oncogene c-Kit","CD117"]},"pred":"http://purl.uniprot.org/core/citation","subj":"http://purl.uniprot.org/uniprot/P10721","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Serine/threonine-protein kinase 10","Lymphocyte-oriented kinase"]},"pred":"http://purl.uniprot.org/core/citation","subj":"http://purl.uniprot.org/uniprot/O94804","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["EC12"]},"pred":"http://purl.uniprot.org/core/source","subj":"http://linkedlifedata.com/resource/#_4F3934383034008C","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["EC25"]},"pred":"http://purl.uniprot.org/core/source","subj":"http://linkedlifedata.com/resource/#_50313037323100109","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Sequence analysis of the protein kinase gene family in human testicular germ-cell tumors of adolescents and adults."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"45"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#object","subj":"http://linkedlifedata.com/resource/#_4F3934383034001E","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#object","subj":"http://linkedlifedata.com/resource/#_5031303732310023","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/16175573"}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/citations/18050304","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.20522"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/citation","subj":"http://purl.uniprot.org/uniprot/A7LNP1","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"A new type of MAML2 fusion in mucoepidermoid carcinoma."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"47"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#object","subj":"http://linkedlifedata.com/resource/#_41374C4E5031001","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/18050304"}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/citations/9071574","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/(SICI)1098-2264(199703)18:3<212::AID-GCC7>3.0.CO;2-4"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/citation","subj":"http://purl.uniprot.org/embl-cds/AAA70188.1","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Zinc finger protein 169"]},"pred":"http://purl.uniprot.org/core/citation","subj":"http://purl.uniprot.org/uniprot/Q14929","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["EC2"]},"pred":"http://purl.uniprot.org/core/source","subj":"http://linkedlifedata.com/resource/#_513134393239004F","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Characterization of a YAC contig containing the NBCCS locus and a novel Kruppel-type zinc finger sequence on chromosome segment 9q22.3."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"18"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#object","subj":"http://linkedlifedata.com/resource/#_513134393239008","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/medline/97225201"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/9071574"}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/citations/9523198","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/(SICI)1098-2264(199803)21:3<230::AID-GCC7>3.3.CO;2-G"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["NIP3L","NIP3-like protein X","Adenovirus E1B19K-binding protein B5","BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like","BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A"]},"pred":"http://purl.uniprot.org/core/citation","subj":"http://purl.uniprot.org/uniprot/O60238","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Isolation, mapping, and functional analysis of a novel human cDNA (BNIP3L) encoding a protein homologous to human NIP3."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"21"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#object","subj":"http://linkedlifedata.com/resource/#_4F3630323338001","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/medline/98183799"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/9523198"}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/citations/9694076","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["IFN-alpha-2","LeIF A","Interferon alpha-A","Interferon alpha-2"]},"pred":"http://purl.uniprot.org/core/citation","subj":"http://purl.uniprot.org/uniprot/P01563","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/citation","subj":"http://linkedlifedata.com/resource/#_5030313536330023","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Cancer Gene Ther."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"A defective retroviral vector encoding human interferon alpha 2 can transduce human leukemic cell lines."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"5"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#object","subj":"http://linkedlifedata.com/resource/#_503031353633006","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/medline/98357449"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Cancer Gene Ther."]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/9694076"}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/citations/9713990","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/(SICI)1098-2264(199809)23:1<1::AID-GCC1>3.3.CO;2-Y"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["TP53-target gene 1 protein","TP53-inducible gene 1 protein","Tumor protein p53-activated protein 1"]},"pred":"http://purl.uniprot.org/core/citation","subj":"http://purl.uniprot.org/uniprot/Q9Y2A0","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/source","subj":"http://linkedlifedata.com/resource/#_5139593241300028","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["EC1"]},"pred":"http://purl.uniprot.org/core/source","subj":"http://linkedlifedata.com/resource/#_513959324130001C","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Isolation of a novel TP53 target gene from a colon cancer cell line carrying a highly regulated wild-type TP53 expression system."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"23"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#object","subj":"http://linkedlifedata.com/resource/#_513959324130001","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/medline/98377792"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/9713990"}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/10534768","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/(SICI)1098-2264(199912)26:4<329::AID-GCC7>3.3.CO;2-3"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Isolation and characterization of a novel TP53-inducible gene, TP53TG3."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"26"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"We applied the differential mRNA display method to isolate genes regulated by wild-type TP53 in cells of a colon-cancer line (SW480) in which we had established an inducible TP53 expression system under the control of the lactose operon. Here we report isolation and characterization of a novel TP53-inducible gene, termed TP53TG3 (TP53 target gene 3). Its DNA sequence was identical to sequences present in two BAC clones that had been mapped to chromosome band 16p13. The gene expressed several transcripts by alternative splicing; the two major transcripts, TP53TG3a and TP53TG3b, encoded 124- and 132-amino-acid peptides that were expressed predominantly in testis. Immunohistochemical analysis using cancer cells (HeLa or H1299) that had been transfected with plasmid DNA designed to express the MYC-fused TP53TG3 proteins indicated that these products were present mainly in the cytoplasm 20 hr after transfection. However, 40 hr after transfection, the recombinant proteins had accumulated in the nuclei of some cells. Because no known nuclear localization domain was present in the amino acid sequence, we suspect that this protein plays an important role in the TP53-mediated signaling pathway, when it forms complexes with other protein(s) and is transferred by them into the nucleus. Genes Chromosomes Cancer 26:329-335, 1999."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/10534768"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/10534768","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/citations/10534768","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/10824998","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/(SICI)1098-2264(200006)28:2<138::AID-GCC2>3.0.CO;2-2"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"MOZ is fused to p300 in an acute monocytic leukemia with t(8;22)."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"28"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"We report on the fusion of the monocytic leukemia zinc finger protein (MOZ) gene to the adenoviral E1A-associated protein p300 (p300) gene in acute monocytic leukemia M5 associated with a t(8;22)(p11;q13) translocation. We studied two patients with double-color fluorescence in situ hybridization (FISH) using the yeast artificial chromosome 176C9 and the bacterial artificial chromosome clone H59D10 specific to the MOZ and p300 genes, respectively. Both probes were split in the patients' chromosome metaphase cells, and the two derivative chromosomes were each labeled with both probes. We showed by Southern blot the rearrangement of the MOZ gene, and cloned the fusion transcripts in one patient carrying the t(8;22) by reverse transcription-polymerase chain reaction using MOZ- and p300-specific primers. Both fusion transcripts were expressed. This result defines a novel reciprocal translocation involving two acetyltransferases, MOZ and p300, resulting in an abnormal transcriptional co-activator that could play a critical role in leukemogenesis."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/10824998"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/10824998","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/citations/10824998","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/10862050","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/1098-2264(200008)28:4<415::AID-GCC7>3.0.CO;2-I"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"RT-PCR analysis of the MOZ-CBP and CBP-MOZ chimeric transcripts in acute myeloid leukemias with t(8;16)(p11;p13)."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"28"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"The translocation t(8;16)(p11;p13) is associated with a subtype of acute monocytic leukemia (AML M5) characterized morphologically by erythrophagocytosis and clinically by a poor prognosis. The t(8;16) fuses the MOZ gene from 8p11 with the CBP (also named CREBBP) gene from 16p13. Previously published studies of MOZ and CBP rearrangements in t(8;16)-positive AML have used fluorescence in situ hybridization and Southern blot methodologies, whereas attempts to amplify and to analyze further the chimeric MOZ-CBP and CBP-MOZ transcripts by means of reverse transcriptase-polymerase chain reaction (RT-PCR) have largely been unsuccessful. In the only t(8;16) that has been described at the sequence level using RT-PCR, the CBP-MOZ fusion was found to be out-of-frame, suggesting that the reciprocal MOZ-CBP transcript is the essential one for leukemogenesis. We have developed an RT-PCR strategy that enables us to detect the MOZ-CBP as well as the CBP-MOZ fusions in the two AML M5 with t(8;16)(p11;p13) analyzed. In both leukemias, the combination of a MOZ forward and a CBP reverse primer amplified a strongly expressed 1,128 bp fragment (type I transcript) and a weakly expressed 415 bp fragment (type II transcript). In the type I transcript, nucleotide (nt) 3,745 of MOZ was fused in-frame with nt 284 of CBP, whereas in the type II transcript, nt 3,745 of MOZ was fused out-of-frame with nt 997 of CBP. Nested PCR with a combination of two forward CBP and two reverse MOZ primers amplified CBP-MOZ chimeric transcripts in both cases. Direct sequence analysis showed that nt 283 of CBP was fused in-frame with nt 3,746 of MOZ, that the initiation ATG codon of the CBP gene remained intact, and that there was no mutation or deletion in the part of the CBP gene included in the CBP-MOZ transcript. Thus, the data we present are not informative with regard to the question whether it is the MOZ-CBP or the CBP-MOZ transcript that is leukemogenic. The present RT-PCR method may be of value for rapid identification of the t(8;16) and also for further molecular genetic studies of the two fusion transcripts and their roles in leukemogenesis."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/10862050"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/10862050","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/citations/10862050","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/11284034","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.1116"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Refinement within single yeast artificial chromosome clones of a minimal region commonly deleted on the short arm of chromosome 7 in Wilms tumours."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"31"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"Cytogenetic and molecular data indicate an involvement of genes mapped to the proximal portion of the short arm of chromosome 7 (7p) in Wilms tumours (WTs). We have analysed 38 WTs using a panel of eight microsatellite markers mapped to proximal 7p. Loss of heterozygosity (LOH) in tumour, compared with matched constitutional DNA, was identified in eight cases. To define better the minimal region commonly deleted in these tumours, they were analysed with nine additional markers, mapped within the region of interest. One tumour (case 30) showed LOH for only one marker (D7S510), while maintaining heterozygosity for the two immediately flanking loci (D7S555 and D7S668). This result was confirmed by fluorescence in situ hybridisation analysis, which showed that in the majority (65%) of nuclei from tumour 30 hybridising with a bacterial artificial chromosome clone containing the D7S510 locus, only one signal was visible. Noticeably, both markers defining the limits of the observed deleted region are simultaneously present within two distinct overlapping yeast artificial chromosome (YAC) clones mapped to chromosome bands 7p13-p14. This suggests that the maximum length of the missing DNA fragment was approximately 1.3 Mb, corresponding to the length of the smaller of the two YAC clones. In all other cases that showed LOH, the deletion encompassed the 7p13-p14 region. For this reason, we speculate that the identified interval contains a gene whose inactivation is important for the development of at least a fraction of WTs."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/11284034"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/11284034","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/citations/11284034","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/11433524","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.1152"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Defining a common region of deletion at 13q21 in human cancers."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"31"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"Previous molecular genetic analyses identified a region of deletion at 13q21 in a variety of human cancers, suggesting the existence of a tumor suppressor gene(s) at this locus. In our earlier study on prostate cancer, the region of deletion was confined to a 3.1 cM interval between D13S152 and D13S162. At present, however, no known gene located in this interval has been firmly implicated in cancer, and the region remains too large for gene identification. To fine-map the area of interest, we established a contig of bacterial artificial chromosome (BAC) clones, narrowed the region of deletion by loss of heterozygosity (LOH) and homozygosity-mapping-of-deletion (HOMOD) analyses in different types of cancers, and tested a candidate gene from the region for mutation and alteration of expression in prostate cancers. The contig consisted of 75 overlapping BAC clones. In addition to the generation of 47 new sequence-tagged-site (STS) markers from the ends of BAC inserts, 76 known STS and expressed sequence tag markers were mapped to the contig (25 kb per marker on average). The minimal region of deletion was further defined to be about 700 kb between markers D13S791 and D13S166 by LOH analysis of 42 cases of prostate cancer, and by HOMOD analysis of eight prostate cancer cell lines/xenografts and 49 cell lines from cancers of the breast, ovary, endometrium, and cervix, using 18 microsatellite markers encompassing the deletion region. A gene that is homologous to the WT1 tumor suppressor gene, AP-2rep (KLF12), was mapped in this region and was analyzed for its expression and genetic mutation. In addition to low levels of expression in both normal and neoplastic cells of the prostate, this gene did not have any mutations in a group of aggressive prostate cancers and cell lines/xenografts, as assessed by the methods of polymerase chain reaction-single strand conformational polymorphism analysis and direct sequencing. These studies suggest that a 700 kb interval at 13q21 harbors a tumor suppressor gene(s) that seems to be involved in multiple types of cancer, and that the AP-2rep gene is unlikely to be an important tumor suppressor gene in prostate cancer. The BAC contig and high-resolution physical map of the defined region of deletion should facilitate the cloning of a tumor suppressor gene(s) at 13q21."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/medline/21325991"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/11433524"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/11433524","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/citations/11433524","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/11746976","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.1200"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Transcription factor BACH2 is transcriptionally regulated by the BCR/ABL oncogene."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"32"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"Expression of BCR/ABL, a constitutively active tyrosine kinase, is a primary event in the pathogenesis of chronic myeloid leukemia (CML) and Ph-positive acute lymphoblastic leukemia (Ph+ALL). Inhibition of the BCR/ABL kinase activity in the BV173 CML cell line with STI571 resulted in a significant overexpression of a 10-kb novel mRNA, found to be the human ortholog of the murine Bach2, a B-cell-specific transcription factor. The human BACH2 cDNA is >9,120 bp long and includes an open reading frame of 2,526 bp encoding a protein with a basic leucine zipper (bZip) and a BTB/POZ domain, mediating DNA-binding and heterodimerization. BACH2 was consistently upregulated (2-10-fold) in all 10 Ph+ lymphoid lines tested following BCR/ABL inhibition. In CML myeloid cell lines (n = 8) and BCR/ABL-negative lines (n = 6), BACH2 was either undetectable by Northern blotting or did not change in response to STI571, suggesting that BACH2 repression by BCR/ABL may be specifically relevant to lymphoid transformation. Quantitative RT/PCR revealed a significantly lower level of BACH2 expression in leukocytes from patients with CML (n = 24) as compared to normal individuals (n = 23) (P < 0.0005). Moreover, CD34+ cells treated in vitro with STI571 exhibited a consistent upregulation of BACH2 in 8 of 10 CMLs but in none of the 9 normal individuals tested. Transcription regulation of BACH2 in BCR/ABL-positive cells was exerted via the MEK pathways, as shown by their responses to the U0126-specific inhibitor. Radiation hybrid mapping and FISH revealed that BACH2 is located on chromosome 6, band q15, a region frequently associated with deletions in ALL and non-Hodgkin's lymphoma, suggesting its possible role as a tumor suppressor gene. However, no rearrangement or loss of signal was observed by Southern blotting in 34 lymphomas, 10 B-cell ALLs, or seven reactive lymph nodes. The pattern of BACH2 expression in BCR/ABL-positive cells suggests that transcriptional repression by this regulator is impaired in CML and may contribute to the emergence of lymphoid blast crisis."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/medline/21610698"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/11746976"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/11746976","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/citations/11746976","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/11807984","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.10020"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Identification of the osteopontin gene as a direct target of TP53."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"33"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"The TP53 tumor suppressor gene regulates a number of genes that are involved in cell-cycle inhibition, apoptosis, and maintaining genetic stability. Recently, two genes that have a role in immunosurveillance were identified as downstream targets of TP53. These genes, TAP1 and fractalkine, may contribute to suppress tumor growth through host immunosurveillance. It has been reported that the mouse secreted phosphoprotein osteopontin (Opn) is one of the key cytokines for type 1 immune responses mediated by macrophages. It also was reported that Opn may play a role in suppressing tumor growth in vivo. Here we identified Opn as a Tp53-target gene using mRNA differential display analysis of embryonic fibroblasts from Tp53-deficient mice. Furthermore, we found that Opn expression was upregulated by DNA damage-induced Tp53 activity and by adenovirus-mediated transfer of the human TP53 gene. In addition, a luciferase assay showed that the Opn gene has a functional Tp53-responsive element in its promoter region, and a chromatin immunoprecipitation assay confirmed interaction between the Opn promoter and Tp53 protein in vivo. These results suggest that OPN is a direct transcriptional target of TP53. The TP53-directed regulation of OPN expression suggests a novel model of TP53 participation in immunosurveillance, involving interaction with the host immune system to prevent damaged cells from undergoing malignant transformation."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/11807984"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/11807984","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/11921277","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.10037"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"APC/CTNNB1 (beta-catenin) pathway alterations in human prostate cancers."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"34"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"Genetic alterations serve as beacons for the involvement of specific pathways in tumorigenesis. It was previously shown that 5% of prostate tumors harbor CTNNB1 mutations, suggesting that this tumor type may involve a deregulated APC/CTNNB1 pathway. To explore this possibility further, we searched for mutations in genes implicated in this pathway in 22 samples that included cell lines, xenografts, and primary tumors. We identified seven alterations: two in CTNNB1, three in APC, and two in hTRCP1 (also known as BTRC) which controls the degradation of CTNNB1. Alterations in the CTNNB1 regulatory domain, APC, and hTRCP1 were mutually exclusive, consistent with their equivalent effects on CTNNB1 stability. These results suggest that CTNNB1 signaling plays a critical role in the development of a significant fraction of prostate cancers. Moreover, they provide the first evidence that hTRCP1 plays a role in human neoplasia."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/11921277"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/11921277","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/12007187","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.10071"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Amplification of the telomerase reverse transcriptase (hTERT) gene in cervical carcinomas."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"34"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"The expression of telomerase reverse transcriptase (hTERT), the catalytic component of the telomerase complex, is required for activation of telomerase during immortalization and transformation of human cells. However, the biochemical and genetic mechanisms governing hTERT expression remain to be elucidated. In the present study, we examined hTERT amplification as a potential genetic event contributing to telomerase activation in cervical carcinomas. An amplification of the hTERT gene was found in 1/4 cervical cancer cell lines and 21/88 primary tumor samples derived from the patients with cervical carcinomas. An increase in the hTERT copy number was significantly correlated with higher levels of hTERT protein expression. Moreover, the hTERT alterations with the enhanced hTERT expression were exclusively observed in those tumors with high-risk human papillomavirus infection. Taken together, the hTERT gene amplification, directly or indirectly targeted by human papillomavirus, may be one of the driving forces responsible for upregulation of hTERT expression and activation of telomerase in cervical cancers."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/12007187"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/12007187","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/12007189","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.10073"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"The cancer-related protein SSX2 interacts with the human homologue of a Ras-like GTPase interactor, RAB3IP, and a novel nuclear protein, SSX2IP."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"34"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"The SSX gene family is composed of at least five functional and highly homologous members, SSX1 to SSX5, that are normally expressed in only the testis and thyroid. SSX1, SSX2, or SSX4 may be fused to the SYT gene as a result of the t(X;18) translocation in synovial sarcoma. In addition, the SSX1, SSX2, SSX4, and SSX5 genes were found to be aberrantly expressed in several other malignancies, including melanoma. The SSX proteins are localized in the nucleus and are diffusely distributed. In addition, they may be included in polycomb-group nuclear bodies. Other studies have indicated that the SSX proteins may act as transcriptional repressors. As a first step toward the elucidation of the cellular signaling networks in which the SSX proteins may act, we used the yeast two-hybrid system to identify SSX2-interacting proteins. By doing so, two novel human proteins were detected: RAB3IP, the human homolog of an interactor of the Ras-like GTPase Rab3A; and a novel protein, SSX2IP. RAB3IP did not interact with either SSX1, SSX3, or SSX4 in the yeast two-hybrid system, whereas SSX2IP interacted with SSX3 but not with either SSX1 or SSX4. Further analysis of deletion mutants showed that both RAB3IP and SSX2IP interact with the N-terminal moiety of the SSX2 protein. Immunofluorescence analyses of transfected cells revealed that the RAB3IP protein is normally localized in the cytoplasm. However, coexpression of both RAB3IP and SSX2 led to colocalization of both proteins in the nucleus. Likewise, the SSX2IP protein was found to be colocalizing with SSX2 in the nucleus. By performing glutathione-S-transferase pull-down assays, we found that both RAB3IP and SSX2IP interact directly with SSX2 in vitro. These newly observed protein/protein interactions may have important implications for the mechanisms underlying normal and malignant cellular growth."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/12007189"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/12007189","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/citations/12007189","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/12032658","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1038/sj.cgt.7700460"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Cancer Gene Ther."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Impaired expression of a human septin family gene Bradeion inhibits the growth and tumorigenesis of colorectal cancer in vitro and in vivo."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"9"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"We have identified a novel human septin family gene Bradeion, which is specifically expressed in human colorectal cancer and malignant melanoma. In order to analyze the implications of tumor-specific gene expression, ribozymes and its derivatives were specifically designed and transfected into various colorectal adenocarcinoma cell lines for Bradeion inactivation. We constructed ribozyme expression plasmids controlled by a human tRNA(Val) promoter, and both hammerhead ribozyme and its allosteric derivative maxizyme were used for two different forms of Bradeion mRNA. The sequence-specific cleavage of Bradeion mRNA resulted in significant growth inhibition and G2 arrest in human cancer cell lines, detected by flow cytometry analysis. In addition, in vivo mice studies demonstrated marked tumor growth suppression by the Bradeion-specific ribozymes. Thus, the tumor-specific and selective marker Bradeion also provides valuable tools as a potential target for colorectal cancer therapy."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Cancer Gene Ther."]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/12032658"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Cancer Gene Ther."]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/12032658","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/12203782","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.10108"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Evidence of a role for the INK4 family of cyclin-dependent kinase inhibitors in ovarian granulosa cell tumors."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"35"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"Granulosa cell tumors (GCTs) of the ovary are relatively rare and account for <5% of all ovarian cancers. The molecular pathogenesis of these tumors is not well understood. We tested the hypothesis that cyclin-dependent kinase inhibitors, specifically the inhibitors of the cyclin-dependent kinase 4 (INK4) family, are targets for altered gene expression in GCTs. The status of RB1, INK4A, INK4B, INK4C, INK4D, and ARF in 13 adult and 2 juvenile ovarian GCTs was determined by reverse transcription-polymerase chain reaction of total RNA and exon-specific sequencing of genomic DNA. Tumors showing loss of INK4A expression were assayed further by exon-deletion analysis and methylation-specific PCR. None of the juvenile tumors demonstrated altered expression, but 7/12 (58%) adult GCTs lacked expression of INK4A, INK4B, or both. In one of these cases, we noted a homozygous deletion of the INK4A locus, and in the remaining tumors we found hypermethylation of the promoter region, a mechanism that can lead to gene inactivation. These data support a role for the INK4 family of CDK inhibitors in the biology of GCTs."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/12203782"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/12203782","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/12378523","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.10128"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Developmental anomalies and neoplasia in animals and cells deficient in the large zinc finger protein KRC."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"35"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"The large zinc finger protein KRC binds to the signal sequences of V(D)J recombination and the kappaB motif. Disruption of KRC expression in cell lines resulted in increased cell proliferation, anchorage independence of growth, and uncoupling of nuclear division and cell division. In this report, the function of KRC was studied in a RAG2-deficient blastocyst complementation animal model. KRC-deficient embryonic stem cells were generated by homologous recombination and were introduced into RAG2(-/-) blastocysts to generate KRC(-/-);RAG2(-/-) chimeric mice. The lymphoid compartments of chimeras examined at 5 weeks of age were developed, suggesting that KRC is not essential for V(D)J recombination development. However, by 6 months of age, there was a marked deficit in CD4(+)CD8(+) thymocytes in the chimeras, suggesting that KRC may be involved in T-lymphocyte survival. Additionally, one chimera developed anomalies, including postaxial polydactyly, hydronephrosis, and an extragonadal malignant teratoma. DNA analysis showed that the teratoma was derived from KRC(-/-) embryonic stem cells. The teratoma had compound tissue organization and was infiltrated with B lymphocytes. Subsequently, several immortalized KRC-deficient cell lines were established from the teratoma. In this study, growth anomalies and neoplasia were observed in animals and cells deficient in KRC, and other studies have shown allelic loss occurring at the chromosomal region of the human KRC counterpart in various tumors. We propose that KRC may be a previously unidentified tumor-suppresser gene."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/12378523"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/12378523","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/12508241","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.10150"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Hypermethylation-mediated regulation of CD44 gene expression in human neuroblastoma."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"36"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"The CD44 adhesion receptor is silenced in highly malignant neuroblastomas (NBs) with MYCN amplification. Because its functional expression is associated with decreased tumorigenic properties, CD44 behaves as a tumor suppressor gene in NB and other cancers. Given that the precise mechanisms responsible for CD44 silencing are not elucidated, we investigated whether CD44 expression could be regulated by DNA hypermethylation. The methylation status of CD44 gene promoter and exon 1 regions was analyzed in 12 NB cell lines and 21 clinical samples after bisulfite genomic modification, followed by PCR and single-strand conformation polymorphism analysis and genomic sequencing. The results showed that almost all CD44-negative cell lines displayed hypermethylation in both regions, whereas all CD44-expressing cell lines were unmethylated. These observations correlated with the ability to restore CD44 mRNA and protein expression by treatment of CD44-negative cells with the 5-aza-2'-deoxycytidine demethylating agent. In contrast, no CD44 gene hypermethylation could be detected in 21 NB clinical samples of different stages, irrespective of CD44 expression. Although our results suggest that aberrant methylation of promoter and exon 1 regions is involved in CD44 silencing in NB cell lines, they also indicate that methylation of unidentified regulatory sequences or methylation-independent mechanisms also control the expression of CD44 in primary NB tumors and cell lines. We therefore conclude that CD44 silencing is controlled by complex and tumor cell-specific processes, including gene hypermethylation. Further investigation of other mechanisms and genes involved in CD44 regulation will be needed before demethylation-mediated reactivation of the CD44 gene can be considered as therapeutic strategy for neuroblastoma and perhaps other related cancers."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/12508241"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/12508241","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/12696061","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.10191"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"37"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"We and others previously identified a region of hemizygous or homozygous deletion at chromosome band 8p23 in oral and oropharyngeal squamous cell carcinomas (OSCCs) and many other cancer types, suggesting the presence of a tumor-suppressor gene (TSG) in this region. Recently, based on a single region of homozygous deletion in head and neck squamous cell carcinomas (HNSCC), a putative TSG, CUB and sushi multiple domains-1 (CSMD1), has been identified. In the present study, we mapped three OSCC cell lines with previously described homozygous deletions at a high resolution onto a detailed physical map. Critically, this map covered a wider region than that used in previous studies, and in contrast to these studies, our results revealed multiple regions of homozygous deletion within a small interval on 8p23. To investigate this deletion pattern further, we generated a panel of 34 sequence tagged site (STS) markers spanning the region and tested these three cell lines and an additional 34 OSCC cell lines, identifying homozygous deletions in a further four. Combining the results from all seven deleted cell lines identified three non-overlapping regions of homozygous deletion. This complex pattern could be consistent with the presence of multiple TSGs or one very large TSG in this region, and/or specific chromosomal instability. CSMD1 spans two of the three deleted regions and, therefore, would appear to be an excellent candidate for a TSG. However, deletion mapping with STSs corresponding to the exons of CSMD1 shows that some of the deletions do not interrupt its coding region, and in other cell lines the coding region is interrupted by two discontinuous homozygous deletions, suggesting the presence of redundant deletions. These results call into question whether the CSMD1 gene is the 8p23 TSG or whether this or any other genes at this locus are involved in the development of OSCC."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/12696061"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/12696061","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/citations/12696061","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/12696073","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.10208"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"BRCA1 mutations."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"37"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/12696073"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/12696073","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/12800156","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.10232"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Non-muscle myosin heavy chain (MYH9): a new partner fused to ALK in anaplastic large cell lymphoma."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"37"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"In anaplastic large cell lymphoma, the ALK gene at 2p23 is known to be fused to NPM, TPM3, TPM4, TFG, ATIC, CLTC, MSN, and ALO17. All of these translocations result in the expression of chimeric ALK transcripts that are translated into fusion proteins with tyrosine kinase activity and oncogenic properties. We report a case showing a restricted cytoplasmic staining pattern of ALK and a novel chromosomal abnormality, t(2;22)(p23;q11.2), demonstrated by fluorescence in situ hybridization analysis. The result of 5' RACE analysis showed that the ALK gene was fused in-frame to a portion of the non-muscle myosin heavy chain gene, MYH9. Nucleotide sequence of the MYH9-ALK chimeric cDNA revealed that the ALK breakpoint was different from all those previously reported. It is localized in the same exonic sequence as MSN-ALK, but 6 bp downstream, resulting in an in-frame fusion of the two partner proteins. In contrast to the previously reported ALK fusion proteins, MYH9-ALK may lack a functional oligomerization domain. However, biochemical analysis showed that the new fusion protein is tyrosine phosphorylated in vivo but seems to lack tyrosine kinase activity in vitro. If further investigations confirm this latter result, the in vivo tyrosine phosphorylation of MYH9-ALK protein could involve mechanisms different from those described in the other ALK hybrid proteins."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/12800156"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/12800156","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/14566860","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.10282"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"NF2: the wizardry of merlin."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"38"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"Neurofibromatosis type II (NF2) is an autosomal dominant cancer syndrome characterized by the formation of tumors of the nervous system, particularly schwannomas and meningiomas. The NF2 gene is also implicated in the development of sporadic schwannomas and meningiomas, as well as tumor types seemingly unrelated to the NF2 disorder, such as malignant mesotheliomas. Inactivation of NF2 occurs by a \"two-hit\" mechanism, as proposed by Al Knudson, and the NF2 gene behaves as a classical tumor suppressor gene. The NF2 gene product, merlin, exhibits homology with the ezrin-radixin-moesin family of membrane-cytoskeleton-linking proteins. During the past several years, there has been intensive investigation aimed at elucidating the mechanisms underlying merlin's functions. In this review, we summarize the involvement of NF2 inactivation in tumorigenesis. We also discuss observations implicating merlin in cell motility and cell proliferation, with a focus on recent findings linking merlin to Rac signaling."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/14566860"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/14566860","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/15101044","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.20025"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Functional consequences of ATM sequence variants for chromosomal radiosensitivity."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"40"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"The ATM [for ataxia-telangiectasia (A-T) mutated] protein plays a key role in the detection and cellular response to DNA double-strand breaks. Several single-nucleotide polymorphisms (SNPs) have been described in the ATM gene; however, their association with cancer risk or radiosensitivity remains to be fully established. In this study, the functional consequences of specific ATM SNPs on in vitro radiosensitivity, as assessed by micronuclei (MN) formation, were measured in lymphoblastoid cell lines established from 10 breast cancer (BC) patients carrying different ATM missense SNPs, six A-T patients, six A-T heterozygotes (A-T het), and six normal individuals. The BC, A-T het, and A-T cell line groups showed significantly higher mean levels of MN formation after exposure to ionizing radiation (IR) than did the group containing normal cell lines, with similar levels in the BC and A-T het groups. Within the BC lines studied, the group composed of the six carrying the linked 2572T>C (858F>L) and 3161C>G (1054P>R) variants had a higher level of MN after IR exposure compared to that observed in the remaining four BC or in the normal cell lines. This increase was not related to the constitutive ATM mRNA level, which was similar in these BC and the normal cell lines. Our results indicate that alterations in the ATM gene, including the presence of heterozygous mutations and the 2572C and 3161G variant alleles, are associated with increased in vitro chromosomal radiosensitivity, perhaps by interfering with ATM function in a dominant-negative manner."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/15101044"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/15101044","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/15287024","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.20062"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Promoter methylation of the PTEN gene is a common molecular change in breast cancer."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"41"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"About 25-50% of women with Cowden disease, a syndrome associated with germ-line mutations of the PTEN gene (at 10q23), develop breast cancer (BC), but PTEN mutations have been found in only 5% of sporadic BCs. However, 29-48% of BCs display loss of heterozygosity in 10q23, and about 40% of BCs show a decrease or absence of PTEN protein levels at the time of diagnosis. Promoter hypermethylation has been identified as an alternative mechanism of tumor-suppressor gene inactivation, but its importance in PTEN silencing in sporadic BC is unknown. We investigated PTEN promoter hypermethylation in 90 sporadic BCs and its correlations with 11 molecular and pathologic parameters, including mRNA levels of PTEN. The study, a methylation-specific PCR assay, was carried out with methylated specific primers designed in a region with scarce homology with the psiPTEN pseudogene. Expression was analyzed by real-time PCR. We found that the PTEN promoter was hypermethylated in 43 BCs (48%). PTEN hypermethylation was associated with ERBB2 overexpression, larger size, and higher histologic grade (P=0.012, 0.03, and 0.009, respectively). We concluded that PTEN promoter hypermethylation is a common event in sporadic BC, correlating with other well-established prognostic factors of this malignancy. Additionally, PTEN mRNA expression was lower in tumors with aberrant methylation."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/15287024"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/15287024","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/15334552","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.20084"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Chromosome band 16q22-linked familial AML: exclusion of candidate genes, and possible disease risk modification by NQO1 polymorphisms."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"41"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"Analyses of chromosomal translocation and inversion breakpoints in sporadic acute myeloid leukemias have identified many transcription factors as playing a role in leukemogenesis. Studies of families with a Mendelian predisposition to hematological malignancies have identified the gene coding for the transcription factor RUNX1 as a leukemia-predisposing gene involved in the first steps of leukemogenesis. Using two families, another autosomal dominant familial leukemia locus was linked to chromosome band 16q22 where the CBFB gene maps. Although CBFB forms a core-binding factor transcriptional complex with RUNX1, previous analyses have excluded the CBFB gene as the leukemia-predisposing gene in these families. In the current study, we performed an extended molecular analysis in these families of the four other transcription factor genes in the 16q22 critical region as well as of two other genes with a known association with leukemia. Several previously undescribed but nonpathogenic sequence variants were identified. We demonstrated that the transcription factors E2F4, CTCF, NFATC3, and NFAT5, and the genes coding for NAD(P)H:quinone oxido-reductase 1 (NQO1) and for E-cadherin are not responsible for the leukemia susceptibility in these families. The presence of NQO1 polymorphisms may suggest a role for this gene in disease risk modification in these families."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/15334552"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/15334552","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/15390181","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.20100"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Acute lymphoblastic leukemia in a patient with Greig cephalopolysyndactyly and interstitial deletion of chromosome 7 del(7)(p11.2 p14) involving the GLI3 and ZNFN1A1 genes."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"42"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"Greig cephalopolysyndactyly (GCPS; OMIM 175700) is an autosomal dominant condition caused by mutations of the gene GLI3, located on 7p13. To date, several cases of deletions and/or translocations involving this locus have been reported in patients with GCPS. GLI3 is a transcription factor from the GLI-Kruppel gene family that has been implicated in three distinct entities: GCPS, Pallister-Hall syndrome, and postaxial polydactyly type A. The zinc finger protein, subfamily 1, member 1 gene (ZNFN1A1; OMIM 603023), on 7p12, codes for a lymphoid-restricted zinc finger transcription factor, ZNFN1A1, also called IKAROS, that regulates lymphocyte differentiation and has been associated with the development of childhood leukemia. We present the case of a 9-year-old Latin-American boy who was referred for stem cell transplantation because of recurrent acute lymphoblastic leukemia (ALL). On evaluation, he was found to have dysmorphic features consistent with GCPS, including a prominent forehead, down-slanting palpebral fissures, 1-2-3 toe syndactyly, broad thumbs and first toes, and mild developmental delay. He had developed ALL at 5 years of age. Chromosome analysis of bone marrow and fibroblastic cells showed an interstitial deletion of chromosome arm 7p, del(7)(p11.2p14), in 74% and 44% of the cells, respectively. We performed FISH analysis with a BAC clone containing the ZNFN1A1 gene and demonstrated that it is contained in the deleted segment. To our knowledge, this is the first report of a patient with GCPS and leukemia. We hypothesize that constitutional deletion of the ZNFN1A1 gene in this patient may have resulted in an increased risk of lymphoid malignancy."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/15390181"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/15390181","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/15887243","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.20200"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"ETV6 gene rearrangements in invasive breast carcinoma."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"44"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"The ETV6/TEL gene encodes a transcription factor frequently rearranged in several types of cancer. We looked for ETV6 rearrangements in invasive breast cancer using fluorescence in situ hybridization (FISH) of BAC probes on sections of tissue microarrays containing 632 tumor samples. Of these samples, signal of sufficient quality for screening by FISH was obtained for 356. Five cases (one lobular, one nontypical secretory, one mixed, and two ductal carcinomas) showed ETV6 rearrangement."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/15887243"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/15887243","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/16252261","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.20280"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Androgen inducibility of Fgf8 in Shionogi carcinoma 115 cells correlates with an adjacent t(5;19) translocation."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"45"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"Fgf8 (fibroblast growth factor 8) was initially cloned from a mouse mammary tumor cell line derived from the androgen-dependent Shionogi carcinoma 115. The androgen-inducible expression of Fgf8 in this tumor controls its androgen-dependent phenotype, thus stimulating interest in this gene as a possible factor in human prostate cancer and other androgen-sensitive cancers. However, apart from Shionogi carcinoma 115, the androgen inducibility of Fgf8 is controversial. In the present study, having not detected androgen-inducible expression of Fgf8 in other mouse mammary cell lines or mouse prostate, we examined the Shionogi carcinoma 115-derived S115 cell line for mouse mammary tumor virus (MMTV) insertions or other nearby DNA rearrangements that might explain the androgen inducibility of Fgf8 in these cells. Southern blotting did not detect MMTV insertions near Fgf8 but did reveal a specific DNA rearrangement 3.7 kb upstream of Fgf8 in S115 cells and in other cells (SC115) independently derived from Shionogi carcinoma 115. Spectral karyotyping of S115 cells and sequencing of the cloned rearrangement junctions indicate that Fgf8 is involved in a t(5;19) translocation. The chromosome 5 sequence joined to Fgf8 is immediately adjacent to Smr2 (submaxillary gland androgen-regulated protein 2) and includes Muc10 (mucin 10), two genes that we show are testosterone inducible in S115 cells, suggesting that the androgen-dependent expression of Fgf8 in Shionogi carcinoma 115 and derivative cells results from this translocation. Together, these results suggest that androgen inducibility is not an inherent property of the Fgf8 gene, which has implications regarding this gene's proposed role in the etiology of hormone-responsive cancers."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/16252261"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/16252261","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/16382448","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.20298"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Identification of a new cancer/testis gene family, CT47, among expressed multicopy genes on the human X chromosome."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"45"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"Cancer/testis (CT) genes are normally expressed in germ cells only, yet are reactivated and expressed in some tumors. Of the approximately 40 CT genes or gene families identified to date, 20 are on the X chromosome and are present as multigene families, many with highly conserved members. This indicates that novel CT gene families may be identified by detecting duplicated expressed genes on chromosome X. By searching for transcript clusters that map to multiple locations on the chromosome, followed by in silico analysis of their gene expression profiles, we identified five novel gene families with testis-specific expression and >98% sequence identity among family members. The expression of these genes in normal tissues and various tumor cell lines and specimens was evaluated by qualitative and quantitative RT-PCR, and a novel CT gene family with at least 13 copies was identified on Xq24, designated as CT47. mRNA expression of CT47 was found mainly in the testes, with weak expression in the placenta. Brain tissue was the only positive somatic tissue tested, with an estimated CT47 transcript level 0.09% of that found in testis. Among the tumor specimens tested, CT47 expression was found in approximately 15% of lung cancer and esophageal cancer specimens, but not in colorectal cancer or breast cancer. The putative CT47 protein consists of 288 amino acid residues, with a C-terminus rich in alanine and glutamic acid. The only species other than human in which a gene homologous to CT47 has been detected is the chimpanzee, with the predicted protein showing approximately 80% identity in its carboxy terminal region."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/16382448"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/16382448","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/citations/16382448","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/16575874","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.20327"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late-stage prostate cancer."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"45"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"Overexpression of the polycomb group protein enhancer of zeste homologue 2 (EZH2) has been found in several malignancies, including prostate cancer, with an aggressive phenotype. Amplification of the gene has previously been demonstrated in several malignancies, but not in prostate cancer. Our goal was to evaluate the gene copy number and expression alterations of EZH2 in prostate cancer. The copy number of EZH2 in cell lines (LNCaP, DU145, PC-3, 22Rv1), xenografts (n = 10), and clinical tumors (n = 191) was studied with fluorescence in situ hybridization. All cell lines had a gain of EZH2. Eight of the ten xenografts showed an increased copy number of the gene, including one case of high-level amplification (>or=5 copies of the gene and EZH2/centromere ratio >or=2). 34/125 (27%) of untreated prostate carcinomas showed increased copy number, but only one case of low-level amplification (>or=5 copies of the gene and EZH2/centromere ratio <2), whereas half (25/46) of the hormone-refractory carcinomas showed increased copy number, including seven cases of low-level amplification and three cases of high-level amplification (P < 0.0001). Expression of EZH2 was significantly (P = 0.0009) higher in hormone-refractory prostate cancer compared with that in benign prostatic hyperplasia or untreated cancer, according to quantitative real-time RT-PCR assay. Also, the expression of EZH2 protein was found to be higher in hormone-refractory tumors than in hormone-naive tumors by immunohistochemistry. The EZH2 gene amplification was significantly (P < 0.05) associated with increased EZH2 protein expression. The data show that amplification of the EZH2 gene is rare in early prostate cancer, whereas a fraction of late-stage tumors contains the gene amplification leading to the overexpression of the gene, thus indicating the importance of EZH2 in the progression of prostate cancer."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/16575874"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/16575874","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/16868940","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.20360"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"A novel region of amplification at 11p12-13 in gastric cancer, revealed by representational difference analysis, is associated with overexpression of CD44v6, especially in early-onset gastric carcinomas."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"45"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"Diffuse-type gastric carcinomas (GCs) are often difficult to characterize because of contamination of tumor samples by surrounding normal tissue. As such, information regarding chromosomal aberrations in this subtype of GCs is limited. In this study, we used representational difference analysis to pinpoint genomic amplifications occurring in diffuse-type GCs. We found nine differential products from two novel regions of amplification in two tumors: one product mapped to 19p13.1 and eight mapped to a 1.8-Mb region in chromosomal segment 11p12-13. These amplifications were confirmed using Southern blot analysis and occurred in 3/16 and 6/15 diffuse-type GCs, respectively. CD44, a well characterized cellular adhesion molecule involved in several human malignancies, is encoded by a gene located within 200 kb of the 11p12-13 amplification fragments. We confirmed that overexpression of isoform CD44v6 was correlated with amplification at 11p12-13 in 11/12 diffuse-type GCs. Since diffuse-type GCs occur more frequently in early-onset gastric carcinomas (EOGCs, presented at 45 years of age or younger) than in \"conventional\" GCs, and the tumors carrying the original amplifications were EOGCs, we investigated overexpression of CD44v6 in 107 EOGCs and 88 conventional GCs using tissue microarrays. We found frequent CD44v6 overexpression in both tumor groups (76% and 57% respectively) and, interestingly, significantly more cases with overexpression of CD44v6 in EOGCs than in conventional GCs (P = 0.005), irrespective of histology. These findings provide further evidence for both the relevance of CD44 in GC and for distinct molecular characteristics of EOGCs when compared with those of GCs occurring at a later age."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/16868940"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/16868940","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/16906560","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.20371"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Comprehensive genome and transcriptome analysis of the 11q13 amplicon in human oral cancer and synteny to the 7F5 amplicon in murine oral carcinoma."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"45"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"11q13 amplification occurs in a wide variety of tumors, including almost half of oral squamous cell carcinomas (OSCC) where it has been correlated with a poor outcome. In this study, we compiled 3.6 Mb of DNA sequence in the 11q13 amplicon core and refined the physical map of the amplicon. In the process, we determined the genomic structure and normal tissue expression patterns of two recently identified genes, TAOS2/TMEM16A and MRGF, which reside in the amplicon core. We then quantified DNA copy number and mRNA expression of all genes in the 11q13 amplicon in cell lines and primary tumors from OSCC. With the exception of FGF3, FGF4, FGF19, and MRGF, all genes were overexpressed in most tumors with genomic amplification. Furthermore, we found that the expression of genes in the amplicon appeared to be highly coordinated, making it difficult to determine which gene or genes are driving amplification. However, in nonamplified primary tumors, three genes, TAOS2/TMEM16A, OCIM, and TPCN2, are frequently overexpressed, whereas CCND1 and EMS1 are not. These results suggest that in addition to CCND1 and EMS1, other important genes also may be target genes driving 11q13 amplification. We hypothesize that 11q13 amplification may be driven by a cassette of genes that provide growth or metastatic advantage to cancer cells. This is supported by the finding that the human 11q13 amplicon core is syntenic to mouse chromosomal band 7F5, which is frequently amplified in chemically induced murine OSCC. This article contains Supplementary Material available at http://www.interscience.wiley.com/jpages/1045-2257/suppmat"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/16906560"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/16906560","obj":null},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/citations/16906560","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/16977606","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.20378"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Mutations in the MYB intron I regulatory sequence increase transcription in colon cancers."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"45"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"Although MYB overexpression in colorectal cancer (CRC) is known to be a prognostic indicator for poor survival, the basis for this overexpression is unclear. Among multiple levels of MYB regulation, the most dynamic is the control of transcriptional elongation by sequences within intron 1. The authors have proposed that this regulatory sequence is transcribed into an RNA stem-loop and 19-residue polyuridine tract, and is subject to mutation in CRC. When this region was examined in colorectal and breast carcinoma cell lines and tissues, the authors found frequent mutations only in CRC. It was determined that these mutations allowed increased transcription compared with the wild type sequence. These data suggest that this MYB regulatory region within intron 1 is subject to mutations in CRC but not breast cancer, perhaps consistent with the mutagenic insult that occurs within the colon and not mammary tissue. In CRC, these mutations may contribute to MYB overexpression, highlighting the importance of noncoding sequences in the regulation of key cancer genes."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/16977606"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/16977606","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/17117415","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.20395"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Characterization of the native CREB3L2 transcription factor and the FUS/CREB3L2 chimera."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"46"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"CREB3L2 was first identified as the 3'-partner of FUS in a fusion gene that seems to be specific for low grade fibromyxoid sarcoma. In silico analyses suggest that the predicted CREB3L2 protein is a member of the CREB3 family of transcription factors, with its bZIP domain being highly similar to that in CREB3L1, CREB3L3, CREB3L4, CREB3, and Drosophila Bbf-2. In the present study, the authors assessed various cellular outcomes after transfection of NIH3T3 and HEK-293 cells with constructs containing full-length and truncated versions of CREB3L2 and FUS/CREB3L2. Northern blot of CREB3L2 mRNA revealed a 7.4 kbp band that contains 0.4 kbp and 5.5 kbp untranslated 5' and 3' regions, respectively. CREB3L2 constructs containing the first 120 amino acids (aa) showed the highest transcriptional activation. Much stronger transcriptional activation was consistently seen for the FUS/CREB3L2 constructs than for the corresponding CREB3L2 constructs. Transcriptional activity was achieved through the box-B element, ATF6 and CRE binding sites, as well as the GRP78 promoter. Proteins encoded by full-length CREB3L2 and FUS/CREB3L2 were localized to reticular structures of the cytoplasm, whereas the corresponding, truncated proteins lacking the transmembrane domain and the carboxy-terminal part of CREB3L2 resided within the nucleus. The results of the present study show that CREB3L2 is not only structurally, but also functionally very similar to CREB3L1. Thus, studies regarding the pathways influenced by wild-type CREB3L2 should provide valuable clues to the pathogenetic significance of the FUS/CREB3L2 chimera in low grade fibromyxoid sarcoma."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/17117415"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/17117415","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/17243160","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.20420"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Gains of REL in primary mediastinal B-cell lymphoma coincide with nuclear accumulation of REL protein."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"46"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"Gains or amplifications of the REL locus are frequently seen in primary mediastinal B-cell lymphoma (PMBL). In classical Hodgkin's lymphoma, genomic overrepresentation of REL correlated with nuclear REL protein accumulation. To investigate the correlation between REL gene copies and its RNA and protein expression in PMBL, we analyzed genomic, transcriptional, and protein levels in 20 PMBLs and the PMBL derived cell lines MedB-1 and Karpas1106P. We found gains/amplifications in 75% of the PMBLs by fluorescence in situ hybridization (FISH) and genomic REL overrepresentation in the PMBL lines. Three of the five PMBLs with amplifications displayed elevated REL transcripts, while only 3/10 PMBLs with gains showed increased REL transcripts by real-time PCR. One PMBL without gains displayed increased REL transcription. REL protein expression exhibited a variable pattern across the PMBLs except for a single case that was completely negative by immunohistochemistry despite having gained REL. Although transcript levels were generally low and nuclear REL staining was weak in the lymphoma cell lines, these nevertheless exhibited high NF-kappaB activation. By fluorescence immunophenotyping and interphase cytogenetics as a tool for investigation of neoplasms, genomic gains/amplifications of REL significantly correlated with nuclear REL expression (P < 0.05). In conclusion, the frequent genomic overrepresentation of REL in PMBL does not necessarily trigger an increased transcription/translation of REL. However, combined genomic and protein analysis revealed a significant association of gained REL and nuclear REL accumulation at the single cell level."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/17243160"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/17243160","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/17551948","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.20467"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Identification of a novel fusion gene MLL-MAML2 in secondary acute myelogenous leukemia and myelodysplastic syndrome with inv(11)(q21q23)."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"46"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"We have identified a novel fusion partner of MLL, namely the mastermind like 2 (MAML2 gene), in secondary acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) with inv(11)(q21q23). RT-PCR and sequencing revealed that exon 7 of MLL was fused to exon 2 of MAML2 in the AML and MDS cells. The inv(11)(q21q23) results in the creation of a chimeric RNA encoding a putative fusion protein containing 1,408 amino acids from the NH2-terminal part of MLL and 952 amino acids from the COOH-terminal part of MAML2. The NH2-terminal part of MAML2, a basic domain including a binding site of the intracellular domain of NOTCH, was deleted in MLL-MAML2. MLL-MAML2 in secondary AML/MDS and MECT1-MAML2 in mucoepithelioid carcinoma, benign Wartin's tumor, and clear cell hidradenoma consist of the same COOH-terminal part of MAML2. A luciferase assay revealed that MLL-MAML2 suppressed HES1 promoter activation by the NOTCH1 intracellular domain. MAML2 involving a chimeric gene might contribute to carcinogenesis in multiple neoplasms by the disruption of NOTCH signaling."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/17551948"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/17551948","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/17620295","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.20476"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Wilms' tumor with an apparently balanced translocation t(X;18) resulting in deletion of the WTX gene."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"46"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"The recent description of a new X chromosome tumor suppressor gene, WTX, that is commonly inactivated in Wilms' tumor prompted us to examine the possible involvement of WTX in a case of Wilms' tumor containing an apparently balanced reciprocal translocation between chromosomes X and 18 (t(X;18)(q11;p11)). Fluorescence in situ hybridization (FISH) analysis of paraffin tumor sections indeed revealed a deletion of the WTX locus at Xq11. High-resolution array comparative genomic hybridization (array CGH) analysis of tumor DNA revealed a 1.5 Mb chromosome deletion encompassing the WTX gene at Xq11. No loss of genetic material was detected on chromosome 18. Interestingly, unlike most tumors with acquired chromosomal translocations, where a new fusion oncogene or promoter-oncogene fusion is created and drives tumor growth, the t(X;18) in this tumor appears to drive tumorigenesis via deletion of a tumor suppressor. This case demonstrates the importance of array CGH and FISH as adjuncts in tumor cytogenetics and in identifying pathogenic microdeletions in \"balanced\" translocations that are not truly balanced."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/17620295"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/17620295","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/17918257","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.20501"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Molecular identification of COL6A3-CSF1 fusion transcripts in tenosynovial giant cell tumors."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"47"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"Tenosynovial giant cell tumors (TGCTs) are benign lesions of the tendon sheaths that primarily affect the fingers, ankles, or feet. Cytogenetic data have shown that 1p13 is most frequently involved in structural aberrations and that 2q37 is its most common translocation partner. The genes involved in the translocation t(1;2)(p13;q37) were recently identified: the colony-stimulating factor-1 (CSF1 or M-CSF1) at 1p13 and the collagen type VI alpha-3 (COL6A3) at 2q37. Based upon the suggestion that a fusion of these genes through the translocation would result in overexpression of CSF1 due to a strong COL6A3 promoter, we performed RT-PCR on six TGCT cases with t(1;2) to search for a putative COL6A3-CSF1 fusion gene. Such fusion transcripts were detected in three cases of which one was an in-frame fusion. In all cases, however, the breakpoints in CSF1 appeared downstream of exon 5, indicating that the amino-terminal part of CSF1, which interacts with its receptor CSF1R, is not encoded by the the chimeric transcripts we identified. The pathogenetic mechanism of these chimeric transcripts is therefore unclear."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/17918257"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/17918257","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/17943974","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.20505"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"47"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"The identification of molecular markers allowing to differentiate between benign and malignant thyroid tumors remains a diagnostic challenge. Herein, we have used the expression of the high mobility group protein gene HMGA2 and its protein, respectively, as a possible marker detecting malignant growth of thyroid tumors. HMGA2 belongs to the high mobility group proteins, i.e. small, highly charged DNA-binding proteins. While HMGA2 is highly expressed in most embryonic tissues, its expression in adult tissues is very low. However, a reactivation of HMGA2 expression has been described for various malignant tumors and often correlates with the aggressiveness of the tumors. The aim of this study was to investigate whether the HMGA2 expression can be used to detect malignant thyroid tumors. RNA from 64 formalin-fixed paraffin-embedded thyroid tissues including normal tissue (n = 3), thyroiditis (n = 2), and follicular adenomas (n = 19) as well as follicular (n = 9), papillary (n = 28), and anaplastic (n = 3) carcinomas was reverse transcribed. Finally, real-time quantitative RT-PCR was performed. Expression differences of up to 400-fold were detected between benign and malignant thyroid tumors. Based on HMGA2 expression alone, it was possible to distinguish between benign and malignant thyroid tissues with a sensitivity of 95.9% and a specificity of 93.9%. There was a highly significant (P < 0.001) difference with histology of the tumors being the gold standard between the benign lesions and malignant tumors. Our results show that even as a stand-alone marker HMGA2 expression has a high potential to improve diagnoses of follicular neoplasms of the thyroid."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/17943974"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/17943974","obj":null}]},"score":0.32735717}
{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Entity","entity":"http://purl.uniprot.org/pubmed/17990328","relations":{"@type":"java.util.ArrayList","@items":[{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.org/dc/terms/identifier","subj":null,"obj":"doi:10.1002/gcc.20514"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/name","subj":null,"obj":"Genes Chromosomes Cancer"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/title","subj":null,"obj":"Amplification of PRKCI, located in 3q26, is associated with lymph node metastasis in esophageal squamous cell carcinoma."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://purl.uniprot.org/core/volume","subj":null,"obj":"47"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/1999/02/22-rdf-syntax-ns#type","subj":null,"obj":"http://purl.uniprot.org/core/Journal_Citation"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":null,"pred":"http://www.w3.org/2000/01/rdf-schema#comment","subj":null,"obj":"DNA amplification is one of the mechanisms to activate genes that are implicated in neoplastic transformation and gain of chromosome band 3q26 is a common event in squamous cell carcinomas. The aim of the present work was to identify the specific target gene from four candidates (MDS1, PRKCI, ECT2, and PIK3CA) located on 3q26 amplification in esophageal squamous cell carcinomas (ESCCs). To assess the prevalence of copy number gains of putative genes, fluorescence in situ hybridization (FISH) was applied on 108 ESCCs and 9 ESCC cell lines. Our data showed that MDS1 and PRKCI were more frequently gained. Positive correlation was found only for PRKCI between amplification and tumor size (P = 0.043), lymph node metastasis (P = 0.015) and clinical stage (P = 0.002). PRKCI gene amplification was highly correlated with protein overexpression (P = 0.009), suggesting that gene amplification is one important mechanism involved in PRKCI overexpression. To investigate further the role of PRKCI alteration in esophageal tumors, a tissue microarray containing samples from 180 ESCCs was used for immunohistochemistry analysis. Statistical analysis revealed that PRKCI overexpression was correlated with lymph node metastasis (P = 0.002) and higher stage (P = 0.004). Performing multivariate logistic regression analysis, a significant association between PRKCI overexpression and presence of lymph node metastasis was found, which was independent of T-stage of the primary tumors (P = 0.004). Our results indicate that PRKCI is an attractive target in the 3q26 amplicon and that it may serve as a molecular marker for metastasis and occult advanced tumor stages in ESCC."},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":null,"obj":"http://purl.uniprot.org/pubmed/17990328"},{"@type":"edu.cmu.lti.oaqa.bio.bioasq.services.LinkedLifeDataServiceResponse$Relation","labels":{"@type":"java.util.ArrayList","@items":["Genes Chromosomes Cancer"]},"pred":"http://www.w3.org/2004/02/skos/core#exactMatch","subj":"http://purl.uniprot.org/pubmed/17990328","obj":null}]},"score":0.32735717}